ArticleOncotarget2018

Comparison of the modified low-dose cytarabine and etoposide with decitabine therapy for elderly acute myeloid leukemia patients unfit for intensive chemotherapy.

Seung-Hwan Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.